Ligand validation:7F9T

MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7F9T_MES_A_1003	56%	8%	0.143	0.915	2.19	2.47	1	5	0	0	100%	1
7F9P_MES_A_903	53%	13%	0.123	0.884	2.12	1.87	1	5	1	0	100%	0.39
7VC5_MES_A_903	45%	13%	0.132	0.862	2.19	1.74	1	3	0	0	100%	0.55
7F9V_MES_A_903	43%	12%	0.156	0.88	2.52	1.55	2	2	0	0	100%	0.89
7FAK_MES_A_903	35%	13%	0.195	0.884	1.84	2.09	1	3	0	0	100%	0.31
7EVU_MES_B_903	20%	18%	0.213	0.818	2.28	1.3	1	2	2	0	100%	0.72
2IUY_MES_B_1355	100%	9%	0.026	0.997	1.73	2.73	1	7	0	0	100%	1
3DPJ_MES_A_192	100%	8%	0.022	0.995	2.2	2.41	1	6	3	0	100%	1
5A0C_MES_B_1002	100%	11%	0.033	0.993	1.84	2.39	3	3	0	0	100%	1
8AJQ_MES_H_201	100%	38%	0.037	0.992	1.52	0.93	1	1	0	0	100%	1
5APG_MES_A_1187	100%	12%	0.044	0.99	1.48	2.57	3	6	0	0	100%	0.9292

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.